Checkpoint Therapeutics Q1 EPS $(0.19) Misses $(0.17) Estimate

Checkpoint Therapeutics (NASDAQ: CKPT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 42.42 percent increase over losses of $(0.33) per share from the same period last year.